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Summary Advances in microbubble pharmacology together with novel ultrasound technolo-
gies are leading to new emerging applications for both assessment and treatment of stroke
patients. Ultrasound perfusion imaging, for example, has added new perspectives for diagnosis
and monitoring of both ischemic and hemorrhagic stroke. Real-time brain perfusion imaging
of cerebral infarctions is now possible and quantitative algorithms for evaluation of regional
cerebral blood ﬂow are being applied for the ﬁrst time in humans. There is growing interest
in therapeutic applications of ultrasound, particularly in the ﬁeld of sonothrombolysis. Recent
results indicate that ultrasound and microbubbles may be effective in clot lysis of ischemicDrug delivery;
BBB stroke even without additional thrombolytic drugs. Moreover, this combination may be effective
in treating themicrocirculation, which will give new dimensions to the application of sonothrom-
bolysis in stroke patients. Further therapeutic avenues include opening of the blood—brain
barrier (BBB) with ultrasound and microbubbles to enable novel drug delivery to the brain.
© 2012 Elsevier GmbH.
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Open access under CC BY-NC-ND license.Brain perfusion imaging — towards new
clinical applications
The most important advance in brain perfusion imaging dur-
ing the last several years has been low-mechanical index
(MI) real time perfusion scanning. This technique allows the
detection of ultrasound contrast agent (UCA) in the cerebral
microcirculation with little or no bubble destruction as com-
pared to the high MI-imaging. Because of minimal contrast
agent bubble destruction, a high frame rate can be applied,
which leads to a better time resolution of bolus kinetics
(Fig. 1). Low-MI imaging of contrast agent also avoids the
shadowing effect, a signiﬁcant problem associated with high
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Open access under CC BY-NC-ND license.echanical index imaging. Because of the high acoustic
ntensities that are emitted by bursting bubbles, bubbles
hat are ‘‘behind’’ the emitting bubbles (further away from
he ultrasound transducer) are ‘‘shadowed’’ by this effect
nd thus obscured from data analysis. Thus, areas of tissue
hat are shadowed may not be available for analysis of tissue
erfusion. The problem of shadowing is basically eliminated
ith low mechanical index imaging, since bubbles are not
estroyed with such low acoustic pressures. Moreover, the
echnique can obtain multi-planar real-time images of brain
erfusion [1]. This is a signiﬁcant breakthrough for ultra-
ound perfusion imaging, since previous approaches were
onﬁned to a single image plane and therefore limited in
heir assessment of the extents of brain infarction and low
erfusion states. The disadvantage of this new low-MI tech-
ique, however, is the limited investigation depth due to the
ow MI used. Recent technological advances suggest, how-
ver, that perfusion imaging of the contralateral hemisphere
hrough the temporal bone window will be possible.
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Figure 1 Real-time acoustic intensity curve of the contrast agent SonoVueTM after bolus injection on a Philips IU22 platform using
a 1—5MHz dynamic pulsed array transducer. A very low mechanical index of 0.017 is used, which is then attenuated about 90% by
the skull bone before entering the brain. A region of interest has been drawn in the upper image to determine where mean acoustic
intensity will be measured. The smaller images in the middle of the ﬁgure are the individual image frames at 14Hz. The red curve
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sisplays the mean acoustic intensity of contrast bolus arrival fr
If a constant concentration of contrast agent is deliv-
red to brain tissue using a constant UCA infusion rate, then
fter destruction with high MI ultrasound, new microbub-
les will enter this ﬁeld with a certain velocity, will travel a
etermined distance and ﬁll a certain tissue volume depend-
ng on blood velocity. The intensity of the echo response
ignal is directly related to the contrast agent concentra-
ion in the tissue; therefore, the blood ﬂow assessment is
ased on monitoring the intensity of the echo response signal
f the insonated volume after bubbles destruction. Low-
I ultrasound imaging can be used to monitor microbubble
eplenishment in real time (Fig. 2) following the applica-
ion of destruction pulses at high MI. The behavior of the
eﬁll kinetics can be assessed with an exponential curve ﬁt
2]. The parameters of this exponential curve are related to
erebral blood ﬂow: blood ﬂow velocity is directly related to
he rate constant ˇ, the fractional vascular volume is related
o the plateau echo enhancement (A), and the product of
oth (A ·ˇ) is associated with blood ﬂow [3]. More sophisti-
ated algorithms for characterization of microbubble reﬁll
ave been recently introduced [4,5], which should increase
eproducibility and improve the quantiﬁcation of cerebral
lood ﬂow with ultrasound perfusion imaging.Since individual microbubbles can be depicted ﬂowing
hrough small vessels in the brain with low MI imaging, it
s possible to track these bubbles and map perfusion over
ime. Dynamic microvascular microbubble maps provide
U
i
a
ghe region of interest for a total of 264 frames during 18.81 s.
xcellent demarcation of MCA infarctions (Fig. 3) and pro-
ide impressive displays of low velocity tissue microbubble
eﬁll following destruction with high mechanical index imag-
ng. In brain regions showing delayed contrast bolus arrival
n perfusion-weighted MRI, ultrasound shows decreased
r absent microbubble reﬁll kinetics. This new technique
as been applied for diagnosis of acute ischemic stroke.
ecent results demonstrate that real-time ultrasound per-
usion imaging with analysis of microbubble replenishment
orrectly identiﬁes ischemic brain tissue in acute MCA stroke
6]. Pulse compression methods are being combined with
he nonlinear bubble imaging techniques discussed above for
ighly sensitive contrast imaging with very low noise. These
dvances will lead to further improvements of microbubble
maging of the brain microcirculation, making ultrasound
erfusion imaging a viable application for bedside assess-
ent of acute stroke patients.
herapeutic applications of ultrasound —
onothrombolysisltrasound applied as an adjunct to thrombolytic therapy
mproves recanalization of occluded intracerebral vessels
nd microbubbles can amplify this effect. New data sug-
est that ultrasound and microbubbles alone may be as
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Figure 2 Real-time acoustic intensity curve of the contrast agent SonoVueTM demonstrating reﬁll following bubble destruction
with transient high mechanical index imaging. Mean acoustic intensity is measured in the region of interest in the upper image. The
smaller images in the middle of the ﬁgure are the individual image frames at 14Hz. The yellow arrow shows the ﬁrst of a series of
high mechanical index images for microbubble destruction.
Figure 3 Microvascular map of left MCA infarction (arrows) characterized by absent or diminished contrast agent. The excellent
infarction demarcation compares well with MRI diffusion-weighted imaging (bottom images).
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lffective as t-PA thrombolysis and also safer with less risk of
emorrhage [7,8].
Ultrasound-sensitive thrombolytic drug delivery com-
ined with speciﬁc targeting is highly attractive. Targeting
f clot-dissolving therapeutics can potentially decrease the
requency of complications while simultaneously increasing
reatment effectiveness by concentrating the available drug
t the desired site and permitting a lower systemic dose [9].
Clinical studies support the use of ultrasound for therapy
f ischemic stroke, and ﬁrst trials of enhancing sonothrom-
olysis with microbubbles have been encouraging. A recent
eta-analysis of all published clinical sonothrombolysis
tudies conﬁrmed that ultrasound and tPA (with or with-
ut microbubbles) increases recanalization compared to
PA alone [10]. These observations have led to design
f CLOTBUSTER, a phase III controlled clinical trial of
onothrombolysis.
onothrombolysis of spontaneous intracranial
emorrhages
ne emerging clinical application is sonothrombolysis of
ntracranial hemorrhages for clot evacuation using catheter-
ounted transducers. As compared with MISTIE (Minimally
nvasive Surgery plus T-PA for Intracerebral Hemorrhage
vacuation) and CLEAR (Clot Lysis Evaluating Accelerated
esolution of Intraventricular Hemorrhage II) studies data,
he rate of lysis during treatment for IVH and ICH was faster
n patients treated with sonothrombolysis plus rt-PA versus
t-PA alone [11]. Thus, lysis and drainage of spontaneous ICH
nd IVH with a reduction in mass effect can be accomplished
apidly and safely through sonothrombolysis using stereotac-
ically delivered drainage and ultrasound catheters via a bur
ole.
RI-guided focused ultrasound for clot lysis
istotripsy is a process which fractionates soft tissue through
ontrolled cavitation using focused, short, high-intensity
ltrasound pulses. Histotripsy can be used to achieve effec-
ive thrombolysis with ultrasound energy alone at peak
egative acoustic pressures >6MPa, breaking down blood
lots in about 1.5—5min into small fragments less than 5m
iameter [12]. Recent developments in using MR-guided
ocused ultrasound therapy through the intact skull suggest
hat this technology could be useful for clot lysis in humans.
xperimental studies are currently being undertaken to test
his possibility, both in ischemic and hemorrhagic stroke.
ltrasound and microbubbles for treatment of the
icrocirculation
ltrasound and microbubbles may improve ﬂow to the
icrocirculation irrespective of recanalization, thus open-
ng new opportunities for application of sonothrombolysis
n acute ischemic stroke. This was suggested by results of
study on possible adverse bioeffects [13] of 2MHz ultra-
ound and microbubbles (SonovueTM) in a middle cerebral
rtery permanent occlusion model in rats at different steps
n the cascade of tissue destruction after ischemic stroke
a
r
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14]. While deleterious effects were not observed, infarc-
ions were unexpectedly smaller in the treatment group,
espite the fact that in all animals recanalization of the MCA
id not occur. This suggested a beneﬁcial effect of ultra-
ound and microbubbles in the microcirculation. A similar
issue protective effect has been found in an in vivo ani-
al study using intravenous microbubbles and transthoracic
ltrasound to treat acute coronary thromboses. Pigs treated
ith ultrasound and intravenous perﬂuorocarbon microbub-
les (PESDA) had signiﬁcantly greater improvements in ST
egments over a 30-minute treatment period when com-
ared with pigs treated with ultrasound alone or with control
nimals. Moreover, there was a signiﬁcantly smaller myocar-
ial contrast defect size after treatment with ultrasound
nd PESDA [15]. Recently, nano-CT was used to demon-
trate complete reversal of microcirculatory impairment in
rodent reperfusion model following treatment with rt-PA,
ltrasound and microbubbles [16]. The mechanism of the
icrocirculatory effect of ultrasound and microbubbles may
nvolve improvement of blood ﬂow to risk tissue via col-
aterals and changes in the microenvironment of damaged
issue, like decreased cell damaging factors, e.g. glutamate
r enhanced enzyme activity of endothelial nitric oxide [17].
urther work is necessary to elucidate the exact mecha-
isms of salvaging of tissue-at-risk by ultrasound-mediated
icrobubble thrombolysis.
pening the blood—brain barrier with focused
ltrasound and microbubbles
he blood—brain barrier is a signiﬁcant obstacle for delivery
f both small molecules andmacromolecular agents. Indeed,
otential therapeutic substances, which cannot be applied
n the presence of an intact BBB are neuropeptides, proteins
nd chemotherapeutic agents. Likewise, large-molecules
uch as monoclonal antibodies, recombinant proteins, anti-
ense, or gene therapeutics do not cross the BBB.
There is a good deal of evidence showing that ultra-
ound can be used to permeate blood-tissue barriers. Large
olecules and genes can cross the plasma membrane of cul-
ured cells after application of acoustic energy [18]. Indeed,
lectron microscopy has revealed ultrasound-induced mem-
rane porosity in both in vitro and in vivo experiments [19].
igh-intensity focused ultrasound has been shown to allow
elective and non-destructive disruption of the BBB in rats
20]. If microbubbles are introduced to the blood stream
rior to focused US exposure, the BBB can be transiently
pened at the ultrasound focus without acute neuronal dam-
ge [21]. Thus, the introduction of cavitation nuclei into the
lood stream can conﬁne the ultrasound effects to the vas-
ulature and reduce the intensity needed to produce BBB
pening (Fig. 4). This can diminish the risk of tissue damage
nd make the technique more easily applied through the
ntact skull. In most studies, the conﬁrmation of BBB disrup-
ion has been obtained with MR contrast imaging at targeted
ocations [21—23] or with post mortem histology [20,24].
Targeted delivery of antibodies to the brain has been
ccomplished with focused ultrasound. Dopamine D(4)
eceptor-targeting antibody was injected intravenously and
hown to recognize antigen in the murine brain follow-
ng disruption of the BBB with ultrasound [22]. Likewise,
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Figure 4 Example of blood—brain disruption by ultrasound
and microbubbles in a rat brain. Extravasation of Evans blue
marks BBB disruption. Exposure time was 20 s with a 1MHz sec-
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[tor transducer at a pressure amplitude of 2.5MPa through the
rat skull with about 50% attenuation.
doxorubicin, a chemotherapeutic drug that does not cross
the BBB, has been administered to the brain using ultra-
sound and microbubbles [25]. Different levels of doxorubicin
in the brain were accomplished through alteration of the
microbubble concentration. These results are encouraging
and provide an important framework for future studies
aimed at local disruption of the BBB for delivery of macro-
molecular agents to the brain.
Several avenues of transcapillary passage after ultra-
sound sonication have been identiﬁed. These include
transcytosis, passage through endothelial cell cytoplas-
mic openings, opening of tight junctions and free passage
through injured endothelium [26]. One study investigated
the integrity of the tight junctions (TJs) in rat brain
microvessels after BBB disruption by ultrasound bursts (1.5-
MHz) in combination with Optison [27]. BBB disruption, as
evidenced by leakage of i.v. administered horseradish perox-
idase (HRP) and lanthanum chloride, was paralleled by the
apparent disintegration of the TJ complexes, the redistri-
bution and loss of the immunosignals for occludin, claudin-5
and ZO-1. At 6 and 24 h after sonication, no HRP or lan-
thanum leakage was observed and the barrier function of
the TJs, as indicated by the localization and density of
immunosignals, appeared to be completely restored. The
results of these studies demonstrate that the effect of ultra-
sound upon TJs is very transient, lasting less than 4 h.
Although much effort has been undertaken to demon-
strate the safety of BBB opening with ultrasound and
microbubbles, further work is needed to elucidate the
molecular effects of this application. Recent data demon-
strate that at the upper thresholds of acoustic pressure
for safe BBB opening a reorganization of gap-junctional
plaques in both neurons and astrocytes may occur [28].
This is important because gap junctions allow transfer of
information between adjacent cells and are responsible for
tissue homeostasis. Likewise, there is evidence that focused
ultrasound-induced opening of the BBB in the presence of
ultrasound contrast agents can lead to increased ubiqui-
tinylation of proteins in neuronal cells [29], indicating thatand CNS drug delivery 9
rain molecular stress pathways are affected by this treat-
ent. Nevertheless, this new technology for delivering drugs
cross the BBB will offer exciting opportunities for treat-
ent of a variety of brain diseases in the future.
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